Please note that the idea of hedging is meant to counter the turbulence of the glove stocks. I still continue to believe Harta has its own potential upside but with market sentiments swaying, it would be advisable to not put all your eggs in one basket. At the same time, I do not advocate speculating in penny stocks like the pharmas. My definition of penny stocks are stocks with no proven track record and are trading at ridiculous prices relative to their profits.

I only would advocate hedging stocks with the following criteria:

1. proven track record and profit growth.
2. strong management team and visible corporate earnings,
3. transparent management ideas such as presentations and press releases so we know what is going on with the company.
4. glove related preferably as glove demand will continue to be elevated.
5. strong fundamentals and relatively low PE ratio
6. current price still demonstrates an upside (massive upside 30% or more) and not over-priced so that there is still gain to be made without investors taking ridiculous risks.

For the benefit of members, I have considered 2 hedging glove-related stocks:

DANONCE TECHNOLOGY (7114)
SAMCHEM (5147)

Both are suppliers to the glove and healthcare industry and they are now trading at a relatively low PE ratio and stock price. D'nonce is an especially good pick as its Q2 is coming out in 30 days time and for the last 3 quarters it has been recording profit growth. The recent corporate presentation and management mentioned they're currently experiencing very strong orders and are operating at maximum capacity, in tandem with the robust demand for gloves.

From its recent corporate presentation, and google map, we can guess with high accuracy that TOPGLOV Thailand and Sri Trang Glove are their clients.

Currently projecting a base case RM 15m of net profit for FY2021, which translate into 5.7c eps FY2021. Extrapolating that into 15x PE based on conservative valuation. TP by analyst: 0.8-1.0

Samchem is a chemicals company supplying chemicals to glove companies to manufacture gloves. Also a solid company with strong fundamentals and growing profits. TP by analyst: 1.23

This is not a buy call, just for the members hedging thoughts. Let me know if you agree after you read up more on these stocks and their business.

Please note that the idea of hedging is meant to counter the turbulence of the glove stocks. I still continue to believe Rubberex has its own potential upside but with market sentiments swaying, it would be advisable to not put all your eggs in one basket. At the same time, I do not advocate speculating in penny stocks like the pharmas. My definition of penny stocks are stocks with no proven track record and are trading at ridiculous prices relative to their profits.

I only would advocate hedging stocks with the following criteria:

1. proven track record and profit growth.
2. strong management team and visible corporate earnings,
3. transparent management ideas such as presentations and press releases so we know what is going on with the company.
4. glove related preferably as glove demand will continue to be elevated.
5. strong fundamentals and relatively low PE ratio
6. current price still demonstrates an upside (massive upside 30% or more) and not over-priced so that there is still gain to be made without investors taking ridiculous risks.

Please note that the idea of hedging is meant to counter the turbulence of the glove stocks. I still continue to believe comfort has its own potential upside but with market sentiments swaying, it would be advisable to not put all your eggs in one basket. At the same time, I do not advocate speculating in penny stocks like the pharmas. My definition of penny stocks are stocks with no proven track record and are trading at ridiculous prices relative to their profits.

I only would advocate hedging stocks with the following criteria:

1. proven track record and profit growth.
2. strong management team and visible corporate earnings,
3. transparent management ideas such as presentations and press releases so we know what is going on with the company.
4. glove related preferably as glove demand will continue to be elevated.
5. strong fundamentals and relatively low PE ratio
6. current price still demonstrates an upside (massive upside 30% or more) and not over-priced so that there is still gain to be made without investors taking ridiculous risks.

Please note that the idea of hedging is meant to counter the turbulence of the glove stocks. I still continue to believe TOPGLOVE has its own potential upside but with market sentiments swaying, it would be advisable to not put all your eggs in one basket. At the same time, I do not advocate speculating in penny stocks like the pharmas. My definition of penny stocks are stocks with no proven track record and are trading at ridiculous prices relative to their profits.

I only would advocate hedging stocks with the following criteria:

1. proven track record and profit growth.
2. strong management team and visible corporate earnings,
3. transparent management ideas such as presentations and press releases so we know what is going on with the company.
4. glove related preferably as glove demand will continue to be elevated.
5. strong fundamentals and relatively low PE ratio
6. current price still demonstrates an upside (massive upside 30% or more) and not over-priced so that there is still gain to be made without investors taking ridiculous risks.

Please note that the idea of hedging is meant to counter the weakness of market sentiments here in Samchem. I still continue to believe samchem has its own potential upside but with market sentiments swaying, it would be advisable to not put all your eggs in one basket. At the same time, I do not advocate speculating in penny stocks like the pharmas. My definition of penny stocks are stocks with no proven track record and are trading at ridiculous prices relative to their profits.

I only would advocate hedging stocks with the following criteria:

1. proven track record and profit growth.
2. strong management team and visible corporate earnings,
3. transparent management ideas such as presentations and press releases so we know what is going on with the company.
4. glove related preferably as glove demand will continue to be elevated.
5. strong fundamentals and relatively low PE ratio
6. current price still demonstrates an upside (massive upside 30% or more) and not over-priced so that there is still gain to be made without investors taking ridiculous risks.

For the benefit of members, I have considered the following hedging glove-related stock:

DANONCE TECHNOLOGY (7114)

Both are suppliers to the glove and healthcare industry and they are now trading at a relatively low PE ratio and stock price. D'nonce is an especially good pick as its Q2 is coming out in 30 days time and for the last 3 quarters it has been recording profit growth. The recent corporate presentation and management mentioned they're currently experiencing very strong orders and are operating at maximum capacity, in tandem with the robust demand for gloves.

From its recent corporate presentation, and google map, we can guess with high accuracy that TOPGLOV Thailand and Sri Trang Glove are their clients.

Currently projecting a base case RM 15m of net profit for FY2021, which translate into 5.7c eps FY2021. Extrapolating that into 15x PE based on conservative valuation. TP by analyst: 0.8-1.0


This is not a buy call, just for the members hedging thoughts. Let me know if you agree after you read up more on these stocks and their business.
28/08/2020 8:39 PM

For the benefit of members, I have considered 2 hedging glove-related stocks:

DANONCE TECHNOLOGY (7114)
SAMCHEM (5147)

Both are suppliers to the glove and healthcare industry and they are now trading at a relatively low PE ratio and stock price. D'nonce is an especially good pick as its Q2 is coming out in 30 days time and for the last 3 quarters it has been recording profit growth. The recent corporate presentation and management mentioned they're currently experiencing very strong orders and are operating at maximum capacity, in tandem with the robust demand for gloves.

From its recent corporate presentation, and google map, we can guess with high accuracy that TOPGLOV Thailand and Sri Trang Glove are their clients.

Currently projecting a base case RM 15m of net profit for FY2021, which translate into 5.7c eps FY2021. Extrapolating that into 15x PE based on conservative valuation. TP by analyst: 0.8-1.0

Samchem is a chemicals company supplying chemicals to glove companies to manufacture gloves. Also a solid company with strong fundamentals and growing profits. TP by analyst: 1.23

This is not a buy call, just for the members hedging thoughts. Let me know if you agree after you read up more on these stocks and their business.

For the benefit of members, in light of massive turbulence in the glove stocks, I have considered 2 hedging glove-related stocks:

DANONCE TECHNOLOGY (7114)
SAMCHEM (5147)

Both are suppliers to the glove and healthcare industry and they are now trading at a relatively low PE ratio and stock price. D'nonce is an especially good pick as its Q2 is coming out in 30 days time and for the last 3 quarters it has been recording profit growth. The recent corporate presentation and management mentioned they're currently experiencing very strong orders and are operating at maximum capacity, in tandem with the robust demand for gloves.

From its recent corporate presentation, and google map, we can guess with high accuracy that TOPGLOV Thailand and Sri Trang Glove are their clients.

Currently projecting a base case RM 15m of net profit for FY2021, which translate into 5.7c eps FY2021. Extrapolating that into 15x PE based on conservative valuation. TP by analyst: 0.8-1.0

Samchem is a chemicals company supplying chemicals to glove companies to manufacture gloves. Also a solid company with strong fundamentals and growing profits. TP by analyst: 1.23

This is not a buy call, just for the members hedging thoughts. Let me know if you agree after you read up more on these stocks and their business.

For the benefit of members, as promised, I have considered 2 hedging glove-related stocks:

DANONCE TECHNOLOGY (7114)
SAMCHEM (5147)

Both are suppliers to the glove and healthcare industry and they are now trading at a relatively low PE ratio and stock price. D'nonce is an especially good pick as its Q2 is coming out in 30 days time and for the last 3 quarters it has been recording profit growth. The recent corporate presentation and management mentioned they're currently experiencing very strong orders and are operating at maximum capacity, in tandem with the robust demand for gloves.

From its recent corporate presentation, and google map, we can guess with high accuracy that TOPGLOV Thailand and Sri Trang Glove are their clients.

Currently projecting a base case RM 15m of net profit for FY2021, which translate into 5.7c eps FY2021. Extrapolating that into 15x PE based on conservative valuation. TP by analyst: 0.8-1.0

Samchem is a chemicals company supplying chemicals to glove companies to manufacture gloves. Also a solid company with strong fundamentals and growing profits. TP by analyst: 1.23

This is not a buy call, just for the members hedging thoughts. Let me know if you agree after you read up more on these stocks and their business.

For the benefit of members, I have considered 2 hedging glove-related stocks:

DANONCE TECHNOLOGY (7114)
SAMCHEM (5147)

Both are suppliers to the glove and healthcare industry and they are now trading at a relatively low PE ratio and stock price. D'nonce is an especially good pick as its Q2 is coming out in 30 days time and for the last 3 quarters it has been recording profit growth. The recent corporate presentation and management mentioned they're currently experiencing very strong orders and are operating at maximum capacity, in tandem with the robust demand for gloves.

From its recent corporate presentation, and google map, we can guess with high accuracy that TOPGLOV Thailand and Sri Trang Glove are their clients.

Currently projecting a base case RM 15m of net profit for FY2021, which translate into 5.7c eps FY2021. Extrapolating that into 15x PE based on conservative valuation. TP by analyst: 0.8-1.0

Samchem is a chemicals company supplying chemicals to glove companies to manufacture gloves. Also a solid company with strong fundamentals and growing profits. TP by analyst: 1.23

This is not a buy call, just for the members hedging thoughts. Let me know if you agree after you read up more on these stocks and their business.

Please note that the idea of hedging is meant to counter the turbulence of the glove stocks. I still continue to believe carepls has its own potential upside but with market sentiments swaying, it would be advisable to not put all your eggs in one basket. At the same time, I do not advocate speculating in penny stocks like the pharmas. My definition of penny stocks are stocks with no proven track record and are trading at ridiculous prices relative to their profits.

I only would advocate hedging stocks with the following criteria:

1. proven track record and profit growth.
2. strong management team and visible corporate earnings,
3. transparent management ideas such as presentations and press releases so we know what is going on with the company.
4. glove related preferably as glove demand will continue to be elevated.
5. strong fundamentals and relatively low PE ratio
6. current price still demonstrates an upside (massive upside 30% or more) and not over-priced so that there is still gain to be made without investors taking ridiculous risks.

kory1310@ you may wish to consider earning some good upside from these hedging stocks. With their relatively low prices, it would be easier to get a good yield.

For the benefit of members, I have considered 2 hedging glove-related stocks:

DANONCE TECHNOLOGY (7114)
SAMCHEM (5147)

Both are suppliers to the glove and healthcare industry and they are now trading at a relatively low PE ratio and stock price. D'nonce is an especially good pick as its Q2 is coming out in 30 days time and for the last 3 quarters it has been recording profit growth. The recent corporate presentation and management mentioned they're currently experiencing very strong orders and are operating at maximum capacity, in tandem with the robust demand for gloves.

From its recent corporate presentation, and google map, we can guess with high accuracy that TOPGLOV Thailand and Sri Trang Glove are their clients.

Currently projecting a base case RM 15m of net profit for FY2021, which translate into 5.7c eps FY2021. Extrapolating that into 15x PE based on conservative valuation. TP by analyst: 0.8-1.0

Samchem is a chemicals company supplying chemicals to glove companies to manufacture gloves. Also a solid company with strong fundamentals and growing profits. TP by analyst: 1.23

This is not a buy call, just for the members hedging thoughts. Let me know if you agree after you read up more on these stocks and their business.

This stock is being primed for a shoot up...been following the price action last few weeks. a lot of collection, moving slowly but steadily. not many sellers. people who buy a firm believers of this stock...definitely a solid one.

very likely...today is a lot of consolidation and collection at low prices the way I observe it. from morning to afternoon till closing, a lot of collection. just look at the volume of shares traded. I feel sad for those who sell. like I said, no need to dump the shares cheap. anything below 4.0 is a definite no no...

very impressive Annual Report released. growth areas clearly highlighted, giving a glimpse of the next QR result to be released soon next month...truly a gem.

maybe more than that...

WYCHAN@ 3.00 is not a realistic price in the short term but yes, if it drops to that, definitely have to top up...

THE surge is beginning again...

First may not be the best: Over 30 Covid-19 vaccines in global clinical trials but experts urge caution

The speedy progress of the front runners in the global vaccine race shows that there is a chance for the Covid-19 pandemic to end within two years, as World Health Organisation chief Tedros Adhanom Ghebreyesus said last week.

However, the haste to come up with a vaccine in the global race may endanger lives if it has not undergone enough testing to make sure it is safe and effective.

And in a crisis where the whole world is affected, a "me first" approach or vaccine nationalism will not help, no matter how tempting it may be, experts have warned.

a lot of people want to make gloves but we all know they need time to set up. fastest 1-2 years. But what does that show? it proves only that glove demand is so high that people can wait for 1-2 years to do this business - so the existing glove companies are not overvalued. they are undervalued. because their profits can only increase exponentially while competition remains low these 1-2 years.

Reading the corporate presentation by the CEO and the company, this coming QR result next month is foreseen to be a massive exponential gain from the last quarter...just like gloves. but compared to gloves, this stock price is still relatively undervalued...the results must be very good for the company to want to urgently announce their results and I suspect a massive upside is awaiting. Recommended for short-medium term gain...the good thing to like about this stock is that it has very strong fundamentals backed by a solid quarter-to-quarter profit increase and with the exponential ride with the gloves/healthcare, this company has more potential to make more profits... at the current price, it is indeed a rare gem.

thanks williamwongkl@ for the sentimental hit song by Crowded House. I grow up listening to 80s songs like this. guys take heart. September winter season is coming and this is where the fun will begin again...

Reading the latest Bursa announcements and the last QR report, it seems that the QR results are coming out soon...with the principal officer now just announcing his intention to deal during closed period, the result will need to be released within 30 days according to Bursa listing rules...

kory1310@ Option 1 you need to hold. wait until it hits 5.50 or more again which it will. Q3 results in Nov is the insurance. alternatively Option 2, you can sell when carepls hits 4.00 or more and then play a hedging stock to earn back the losses. I have identified 2 hedging stocks and doing the analysis now on the conservative upside. If there is a 30% gain to be made, then when carepls hits 4 or above, you sell, masuk to the hedging stock and earn back your losses to break even. Update again soon but never sell carpls below 4.0, that is madness.

on the whole, when the big4 goes up, carepls will also go up. not true that all liquidity will flow to big 4 then second liner stocks will drop. Because market is not stupid, when they see the yield% is lesser than the lower price stocks, they will start to pump and buy the lower priced stocks. For example, for you to gain 33%, you need to buy let's say supermax at 9 and sell at 12. Do you know how difficult it is for supermax to increase by 3 bucks after the share capital is increased? it is much easier for carepls to hit a yield of 33% because all it takes is for it to surge from 3.50 to around 4.50...just 1 buck increase for a lower share capital is much easier to achieve...that is why some big stocks drop after bonus issue. Dufu is one example of a technology stock that keeps on dropping awhile after the bonus issue...

Today is a low price day very much like bargain day...good to accumulate if you spot an opportunity. Tuesday sell and you can make a bit to alleviate some stress... buy if you have bullets. carepls seems to be going on sale again...I have identified some good hedging stocks. I will share my analysis for the members here in due course.

another quarter of losses...too much disappointment with this company...

as usual, another no news no show privatization notice. boy crying wolf too long too much. let it drop more...accumulate more on weakness below 60 cents. to profit it is not prudent to accumulate above 60 cents.

no problem NewToThis@ I will update members again soon if I find anything interesting. In the meantime, no need to panic sell...

I think 4.80 is still a good price as the short term fair value is 5.50 range...but I suggest you pare that down by topping up when carepls falls on weakness...in addition, it would be great for you to consider a hedging stock. I trust the healthcare related stocks which supplies raw materials to gloves are undervalued as well. And they enjoy the same measure of exponential profits growth as gloves because they supply materials to gloves. It would be worth considering them - those packaging and chemicals companies....I will in time recommend some to members as I need to read their Q2 reports and track their finances and growth....but I think they ate better hedge than pharma stocks which are very overpriced now...

For the benefit of members here and the glove fans community, I propose a hedge instrument stock to cushion the market turbulence. Many argued for pharma but I personally felt that most pharma stocks with the exception of solution is overpriced and over-valued. It is a ponzi scheme because they have no fundamentals no profits to show for that price. It is all a speculation. The matter is different for gloves where the profits are already locked in until 2021.

I will do some research on a good hedging stock to buy some...and if I find a good one, I will recommend to members to consider reading more. This is not a buy or call sell but merely a suggestion since I understand some members are getting impatient with the volatility of the gloves not moving in the direction that it should be moving. A hedge will cushion your turbulence, give you some gain and make your patience more bearable with gloves... so you don't make the wrong decision to sell your glove stocks...unnecessarily....

NewToThis@ I think the last time we chatted, carepls rose to 4.20... my only message to you is if you need the money, then you have no choice but to quit and hope to re-enter later. but if you have the cash to spare, try to buy on weakness. that will help you pare down your average holding price and I am confident, carepls will hit 5 sometime soon. I don't know when but the market is alwasy right. sectoral rotational buying may happen for days on sentiments. but the market is always directed to fundamentals to profits to growth... on that basis, we just need to be patient. no need to monitor the stock price every hour haha...just top up bit by bit on weakness...when it rise, sell some to regain some capital. buy again on weakness. if this is the market play, then i think this is the best strategy. hold half, buy and sell half based on weakness and sell on strength...

And let me share why I personally love carepls so much...and I prefer it over other glove stocks. You will realise when you buy carepls, that this company has its own brand and that it sells under a unique JV with Ansell which in turn operates in a unique brand market which is different from the other glove companies.

Secondly, I like the fact that it trades at a relatively mid-range PE ratio and hence there is still upside to be gained from the stock. The price is relatively stable and the yield is higher than the big glove companies. So, when you buy carepls you are investing in a potential growth stock ... as a potential growth stock, as an investor, I only want to see more profits...IF THERE IS MORE PROFITS, the stock price will increase. and this is what carepls has shown, exponential growth profits driving its share price to rise from below 50 cents to what it is today - And I believe, the best is yet to come for carepls. why? because the fact is its next Q3 profits will be even better than its Q2... simple... fundamentals and facts... and the facts don't lie...

On another note, President Trump is in a desperate political battle of his life, so whatever he says about the vaccine, I believe we need to corroborate with scientific facts and expert's reports. THIS GUY has proven to be very inconsistent.

kory's 1310@ observations are spot on. I personally do not think that directors of companies will buy more land and invest more monies to expand production lines if glove demand for the next 2-3 years is not hiked. Directors owe fiduciary duties to the company and cannot simply make decisions based on a whim. They must base it on facts and best of all, they are backing it up with their own money as they are also mostly the shareholders. On that account, we know that glove demand remains elevated, WITH OR WITHOUT A VACCINE.

In addition to kory's observations, let me add an interesting observation - Tan Sri Lim of TOPGLOV himself and his family has spent 30-50 mil to buy TG shares, similarly with the shareholders of Kossan and Rubberex I was made to understand. Why do you think they are doing that? Do you think smart billionaires are also in the business of speculating on stocks? do they need to do that? Surely, the potential upside gain must be so much that they are investing...so we need not worry for 2020. Beyond 2020, I have no comments and I believe we need to re-assess the stock price after 2020... so please don't dump your shares cheap now and burn your hard earned money away....there is no truly no logical reason to do that. Nothing has changed, the fundamentals of the gloves companies' have not changed ...in fact all the massive record profits in all the QR reports are only affirming that the show is only going to get better...

guys I have been away awhile and I believe that I wanted to observe the market before making any decisions and or comments. I was researching on the IB reports and vaccine news. I have come to the conclusion that glove demand for 2020 will remain elevated and that the IB reports that the current stock price has fully factored in the ASP premiums may not be accurate after all.

1. Corona cases are still increasing - waves after waves and we have not seen the peak yet - reason being the winter season is just about to begin which means more cases will come in the next few months.
2. Vaccine phase 3 trials take months to complete even on an expedited scale - any thing less than that is not a safe vaccine.
3. ASP hikes may have to stop at some point but not this year. which means for 2020 Q3 and Q4 we will still see exponential growth in profits. Carepls's best results has yet to be released.

Therefore, on this account, I would say 3.50 is undervalued. The full fair price is 5.50 which the stock hit weeks back... with the ASP hikes for Q3 and Q4 which I understand from the glvoe executives are still hiking up this month and next month probably, the fully valued price should be TP: 7-8. On a bullish result, this could even be TP:9.0 ...

ripe for investors' pickings. potential upside is high

a very good undervalued stock ...